An adenovirus-vectored vaccine based on the N protein of feline coronavirus elicit robust protective immune responses
Open Access
- 2 February 2024
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 223, 105825
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Commission of Shanghai Municipality (ZD2021CY001)
- National Key Research and Development Program of China (2023YFD1800700)
- National Natural Science Foundation of China (32000109, 32172832)
This publication has 49 references indexed in Scilit:
- Feline Infectious Peritonitis: ABCD Guidelines on Prevention and ManagementJournal of Feline Medicine and Surgery, 2009
- Vaccine-induced enhancement of viral infectionsVaccine, 2009
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialThe Lancet, 2008
- Nonself RNA-Sensing Mechanism of RIG-I Helicase and Activation of Antiviral Immune ResponsesMolecular Cell, 2008
- Disappearance of Antibodies to SARS-Associated Coronavirus after RecoveryNew England Journal of Medicine, 2007
- Viral evolution and the emergence of SARS coronavirusPhilosophical Transactions of the Royal Society B: Biological Sciences, 2004
- Live, Attenuated Coronavirus Vaccines through the Directed Deletion of Group-Specific Genes Provide Protection against Feline Infectious PeritonitisJournal of Virology, 2004
- Common virus infections in cats, before and after being placed in shelters, with emphasis on feline enteric coronavirusJournal of Feline Medicine and Surgery, 2004
- Antibody-Dependent Enhancement of Feline Infectious Peritonitis Virus Infection in Feline Alveolar Macrophages and Human Monocyte Cell Line U937 by Serum of Cats Experimentally or Naturally Infected with Feline Coronavirus.Journal of Veterinary Medical Science, 1998
- Protection against feline infectious peritonitis by intranasal inoculation of a temperature-sensitive FIPV vaccineVaccine, 1990